The UPC has appointed 21 new technically qualified judges (TQJs) across various areas, including chemistry and pharmaceutics, biotechnology, mechanical engineering, electricity and physics. Following a selection process, the UPC Administrative Committee adopted the final list of recommended candidates on 2 June 2023. Further appointments of TQJs are expected to take place later in 2023, with interviews to be scheduled in the upcoming weeks.
On 2 June 2023, Sanofi-Aventis filed revocation proceedings in UPC in relation to Amgen’s Repatha® (evolocumab), one of the earliest UPC revocation cases filed – only one day after the Court’s commencement.
Print Page Mail Article